# Maxcyte, Inc.: Form 8-K, filed Jan 24, 2022

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2022-01-24
- Accepted by EDGAR: Jan 24, 2022, 17:05 ET
- Period: 2022-01-24
- Accession: 0001104659-22-006977
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000110465922006977/tm224229d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000110465922006977/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000110465922006977/tm224229d1_8k.htm

Filed Jan 24, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-006977. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.